Crossmark

Developing Subcutaneous Formulations for Irisin as a Potential Therapeutic

Published Online: 2025-10-22

Published Print: 2025-12

Authors

Hu, Gang

Luan, Xi

Hageman, Michael J.

Lou, Hao https://orcid.org/0000-0003-0218-6382
Funding

Funding for this research was provided by:

National Center for Advancing Translational Sciences (UL1TR002366)
License Information

Text and Data Mining valid from 2025-10-22

Version of Record valid from 2025-10-22
More Information

Article History

Received: 21 August 2025

Accepted: 26 September 2025

First Online: 22 October 2025

Declarations

:

: None.

Document is current